STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ZBH ZIMMER BIOMET HOLDINGS INCORPORATED StockScouter® Report

5

StockScouter® Score

ZIMMER BIOMET HOLDINGS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • One or more less experienced analysts has modestly increased quarterly earnings estimates for ZBH. Positive/Neutral
  • Shares are under accumulation by financial institutions. Marginally positive for large companies like ZBH

 

Concerns

  • The ratio of ZBH’s forward price-to-earnings multiple to its estimated growth rate is well above the average of comparably-sized companies in the StockScouter universe. Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be out of favor, growth stocks will be neutral, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 20% done.
Progress: 80% done.
Low
High

Core Model Grades

B
C
C
F

Previous Ratings

7
6
6